GILTERITINIB
DrugBank ID: DB12141
Summary
| Metric | Value |
|---|---|
| Total Predictions | 15 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 0 |
| KG Only | 15 |
Predictions
| Indication | Score | Source |
|---|---|---|
| acute myeloblastic leukemia with maturation | nan | KG |
| acute myeloblastic leukemia without maturation | nan | KG |
| acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | nan | KG |
| acute myeloid leukemia with CEBPA somatic mutations | nan | KG |
| acute myeloid leukemia with NPM1 somatic mutations | nan | KG |
| acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | nan | KG |
| acute myeloid leukemia with minimal differentiation | nan | KG |
| acute myeloid leukemia with t(6;9)(p23;q34) | nan | KG |
| acute myeloid leukemia with t(8;16)(p11;p13) translocation | nan | KG |
| acute myeloid leukemia with t(8;21)(q22;q22) translocation | nan | KG |
| acute myeloid leukemia with t(9;11)(p22;q23) | nan | KG |
| inherited acute myeloid leukemia | nan | KG |
| myeloid leukemia | nan | KG |
| therapy related acute myeloid leukemia and myelodysplastic syndrome | nan | KG |
| unclassified acute myeloid leukemia | nan | KG |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.